Physician profile
Andrew Murray
NPI 1356788624
$13,295.66
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,985 · 2020: $6,391 · 2021: $250 · 2022: $2,068 · 2023: $1,477 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,027.78 | 2020 | |
| Abbott Laboratories | $1,817.02 | 2020-2023 | Diamondback Coronary |
| Edwards Lifesciences Corporation | $1,264.89 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,189.06 | 2019 | |
| Boston Scientific Corporation | $925.30 | 2019-2023 | Watchman Flx, Varithena Administration Pack |
| Astrazeneca Pharmaceuticals LP | $460.65 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $453.05 | 2020-2023 | Lifevest |
| Amgen INC. | $383.95 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $376.07 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $300.95 | 2020-2023 | Diamondback Coronary, Diamondback Peripheral |
| Abiomed | $274.45 | 2021-2024 | Impella |
| Sanofi-Aventis U.S. LLC | $184.82 | 2019-2022 | |
| Silk Road Medical, INC. | $154.85 | 2022 | |
| Inari Medical, INC. | $152.80 | 2022 | |
| Teleflex LLC | $127.98 | 2023 | Guideliner |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.